Skip NavigationSkip to Content
Return Return to Search Results

Selection of a novel gp41-specific HIV-1 neutralizing human antibody by competitive antigen panning

  1. Author:
    Zhang, M. Y.
    Choudhry, V.
    Sidorov, I. A.
    Tenev, V.
    Vu, B. K.
    Choudhary, A.
    Lu, H.
    Stiegler, G. M.
    Katinger, H. W. D.
    Jiang, S.
    Broder, C. C.
    Dimitrov, D. S.

  2. Author Address

    NCI, CCRNP, CCR, NIH,Prot Interact Grp, Frederick, MD 21702 USA. NCI, SAIC Frederick Inc, Basic Res Program, Frederick, MD 21702 USA. Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA. New York Blood Ctr, Lindsley F Kimball Res Inst, Lab Viral Immunol, New York, NY 10021 USA. Inst Appl Microbiol, Vienna, Austria.;Zhang, MY, NCI, CCRNP, CCR, NIH,Prot Interact Grp, Bldg 469,Rm 131,POB B,Miller Dr, Frederick, MD 21702 USA.;zhangm@nciferf.gov dimitrov@ncifcrf.gov
    1. Year: 2006
    2. Date: Dec
  2. Journal: Journal of Immunological Methods
    1. 317
    2. 1-2
    3. Pages: 21-30
  4. Type of Article: Article
  5. ISSN: 0022-1759
  1. Abstract:

    The HIV envelope glycoprotein (Env) is composed of two non-covalently associated subunits: gp 120 and gp41. Panning of phage-displayed antibody libraries against Env-based antigens has resulted mostly in selection of anti-gp120 antibodies. Native gp41 in the absence of gp120 is unstable. The use of gp41 fragments as antigens has resulted in selection of antibodies with only relatively modest neutralizing activity. To enhance selection of antibodies specific for gp41 in the context of the whole Env we developed a methodology termed competitive antigen panning (CAP). Using CAP, we identified a novel gp41-specific human monoclonal antibody (hmAb), m48, from an immune library derived from long-term nonprogressors with high titers of broadly cross-reactive neutralizing antibodies (bcnAbs). Selection of m48 was only successful using CAP and not through the conventional pre-incubation methodology. In assays based on spreading infection in peripheral blood mononuclear cells (PBMCs) m48 neutralized a panel of HIV-1 primary isolates from different clades more potently than the well-characterized broadly cross-reactive HIV-1-neutralizing antibodies IgG1 4E10 and Fab Z13. These results may have implications for the selection of novel gp41-specific bcnAbs and other antibodies, and for the development of HIV-1 inhibitors and vaccine immunogens. (c) 2006 Elsevier B.V. All rights reserved.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.jim.2006.09.016
  3. View record in Web of Science®
  4. WOS: 000243148700003

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel